BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/20/2023 7:36:10 AM | Browse: 161 | Download: 420
 |
Received |
|
2023-04-22 04:50 |
|
Peer-Review Started |
|
2023-04-22 04:52 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-05-23 23:56 |
|
Revised |
|
2023-06-05 09:07 |
|
Second Decision |
|
2023-06-27 02:52 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-06-27 09:20 |
|
Articles in Press |
|
2023-06-27 09:20 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2023-07-03 03:49 |
|
Typeset the Manuscript |
|
2023-09-13 02:35 |
|
Publish the Manuscript Online |
|
2023-09-20 07:36 |
| ISSN |
2222-0682 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Compensated liver cirrhosis: Natural course and disease modifying strategies
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ramesh Kumar, Sudhir Kumar and Sabbu Surya Prakash |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ramesh Kumar, MD, Additional Professor, Department of Gastroenterology, All India Institute of Medical Sciences, 4th floor, IPD Block-C, Patna 801507, India. docrameshkr@gmail.com |
| Key Words |
Compensated cirrhosis; Compensated advanced chronic liver disease; Clinical decompensation; Cirrhosis reversal; Disease modifying agents; Acute-on-chronic liver failure |
| Core Tip |
Compensated liver cirrhosis (CLC) might be reversible if the underlying cause is treated before the disease progresses. The median survival for these individuals is typically 10 to 12 years; however, after the first decompensation, it drastically drops to 1 to 2 years. As a result, the outcomes of such patients can be significantly improved by integrating a number of disease-modifying therapy strategies that address complex pathophysiology, risk factors, and triggering events linked with disease progression. This article discusses the natural course of CLC, risk factors for its progression, and potential therapeutic strategies to favourably influence its natural evolution and enhance outcomes. |
| Publish Date |
2023-09-20 07:36 |
| Citation |
Kumar R, Kumar S, Prakash SS. Compensated liver cirrhosis: Natural course and disease modifying strategies. World J Methodol 2023; 13(4): 179-193 |
| URL |
https://www.wjgnet.com/2222-0682/full/v13/i4/179.htm |
| DOI |
https://dx.doi.org/10.5662/wjm.v13.i4.179 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
